Dermatol. praxi. 2020;14(1):30-35 | DOI: 10.36290/der.2020.009

Photoprotection in drug‑induced photosensitivity

doc. MUDr. Karel Ettler, CSc.1, MUDr. Jiří Ettler2
1 Klinika nemocí kožních a pohlavních FN a LF UK v Hradci Králové
2 3. lékařská fakulta UK v Praze

Exposure to solar ultraviolet (UV) radiation can cause immediate or delayed harmful effects in the skin. Such effects can be amplified by topical and systemic drugs that have photosensitising potential. Drug cessation or thorough photoprotection is required. Avoiding direct sun exposure, using protective clothes and sunscreens constitute an effective photoprotection.

Keywords: photosensitising drugs, photoprotection, sunscreens.

Received: January 11, 2020; Revised: January 11, 2020; Accepted: January 16, 2020; Prepublished online: January 16, 2020; Published: March 25, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ettler K, Ettler J. Photoprotection in drug‑induced photosensitivity. Dermatol. praxi. 2020;14(1):30-35. doi: 10.36290/der.2020.009.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ferguson J. Drug‑induced photosensitivity. In: Ferguson J, Dover JS, eds. Photodermatology, London: Manson Publishing; 2006: 67-72. Go to original source...
    2. Habif TP. Exanthems and drug eruptions. In: Habif TP. ed. Clinical Dermatology. St.Louis: Mosby Elsevier; 2010: 580. Go to original source...
    3. Ettler J, Ettler K. Aktuální pohled na fotoprotekci kůže. Dermatol. pro praxi 2016; 10(2): 54-59. Go to original source...
    4. Zuba EB, Koronowska S, Osmola‑Mańk Zuba EB, Koronowska S, Osmola‑MańkowskaA, Jenerowicz D. Drug‑induced Photosensitivity Acta Dermatovenerol Croat 2016; 24(1): 55-64. Go to PubMed...
    5. Layton AM, Cunliffe WJ. Phototoxic eruptions due to doxycycline - a dose related phenomenon. Clin Exp Dermatol 1993; 18: 425-427. Go to original source...
    6. Baran R, Juhlin L. Drug induced photo‑onycholysis. J Am Acad Dermatol 1987; 17: 1013-1016. Go to original source...
    7. Bjellerup M, Ljunggren. Double blind cross‑overstudies on phototoxicity to three tetracycline derivatives in human volunteers. Photodermatology, 1987; 4: 281-287. Go to PubMed...
    8. de Guidi G, Bracchitta G, Catalfo A. Photosensitization reactions of fluoroquinolones and their biological consequences. Photochem Photobiol 2011; 87: 1214-1229. Go to original source...
    9. Ettler K, Gregor J, Pidrman V, Šubrtová D, Nožičková M. Skin side‑effects of amiodarone therapy. Sbor. věd. prací LF UK Hradec Králové 1993; 36(4-5): 305-315.
    10. Pedersen SA, et al. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide casecontrol study from Denmark. J Am Acad Dermatol 2018; 78: 673-681. Go to original source...
    11. Dittrichova D. Fotosenzitivní potenciál léčiv pro zevní i celkové použití. Med. Pro Praxi 2008; 5(10): 385-387.
    12. Bosca F, Miranda MA, Carganico G, Mauleón D. Photochemical and photobiological properties of ketoprofen associated with the benzophenone chromophore. Photochem Photobiol 1994; 60: 96-101. Go to original source...
    13. Youn JI, Lee HG, Yeo UC, Lee YS. Piroxicam photosensitivity associated with vesicular hand dermatitis. Clin Exp Dermatol 1993; 18: 52-54. Go to original source...
    14. Canelas MM, Cardoso JC, Goncalo M, Figueiredo A. Photoallergic contact dermatitis from benzydamine presenting mainly as lip dermatitis. Contact Dermatitis 2010; 63: 85-88. Go to original source... Go to PubMed...
    15. Kowalzick L, Ziegler H. Photoallergic contact dermatitis from topical diclofenac in Solaraze gel. Contact Dermatitis 2006; 54: 348-349. Go to original source... Go to PubMed...
    16. Blakely KM, Drucker AM, Rosen CF. Drug‑Induced Photosensitivity‑An Update: Culprit Drugs, Prevention and Management. Drug Saf. 2019; 42(7): 827-847. doi: 10.1007/s40264-019-00806-5. Go to original source...
    17. Martinasková K, Vorčáková K. Systémové retinoidy v liečbe vybraných dermatóz detského veku. Dermatol. Prax, 2017; 11(2): 54-59.
    18. Bettoli V, Zauli S, Virgili A. Retinoids in the chemoprevention of non‑melanoma skin cancers: why, when and how. J Dermatolog Treat. 2013; 24(3): 235-237. Go to original source... Go to PubMed...
    19. Haylett AK, Felton S, Denning DW, Rhodes LE. Voriconazole‑induced photosensitivity: photobiological assessment of a case series of 12 patients. Br J Dermatol 2013; 168: 179-185. Go to original source...
    20. Slade HB, Shroot B, FeldmanSR, Cargill DI, Stanfield J. Reappraising the phototoxicity of tretinoin: a report of four controlled clinical trials Epub 2013 Feb 3.
    21. Cetiner S, Ilknur T, Ozkan S. Phototoxic effects of topical azelaic acid, benzoyl peroxide and adapalene were not detected when applied immediately before UVB to normal skin. Eur J Dermatol. 2004; 14(4): 235-237.
    22. Ettler K. Fotoprotekce. Edukační projekt České dermatovenerologické společnosti ČSL JEP. Čes‑slov Derm. 2019; 94(4): 178-180.
    23. Normy ISO: ISO 24444:2010, ISO 24443:2012, ISO 24442:2011. Znění dostupné na http://www.iso.org
    24. Tovar‑Sánchez A, Sánchez‑Quiles D, Rodríguez‑Romero A. Massive coastal tourism influx to the Mediterranean Sea: The environmental risk of sunscreens. Sci Total Environ. 2019; 656: 316-321. Go to original source... Go to PubMed...
    25. Fabrikant J, Touloei K, Brown SM. A review and update on melanocyte stimulating hormone therapy: afamelanotide. J Drugs Dermatol. 2013; 12(7): 775-779. Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.